Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$78,433 | -$75,561 | -$62,462 | -$59,312 |
| Dep. & Amort. | $3,729 | $11,076 | $14,111 | $13,699 |
| Deferred Tax | $132 | $318 | $225 | -$1,516 |
| Stock-Based Comp. | $7,918 | $8,416 | $9,429 | $7,911 |
| Change in WC | $3,079 | -$4,818 | $408 | -$10,717 |
| Other Non-Cash | -$52 | $1,632 | -$2,370 | $3,260 |
| Operating Cash Flow | -$63,627 | -$58,937 | -$40,659 | -$46,675 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$561 | -$1,279 | -$1,368 | -$3 |
| Net Acquisitions | -$65,067 | -$48,816 | $118,300 | $0 |
| Inv. Purchases | -$12,268 | -$33,886 | -$122,330 | $0 |
| Inv. Sales/Matur. | $77,335 | $82,702 | $4,030 | $0 |
| Other Inv. Act. | $65,067 | $48,816 | -$118,300 | $0 |
| Investing Cash Flow | $64,506 | $47,537 | -$119,668 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $2,815 |
| Stock Issued | $10,118 | $18 | $131,929 | $47,325 |
| Stock Repurch. | $0 | -$350 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$412 |
| Other Fin. Act. | -$492 | -$332 | $29,776 | $3,642 |
| Financing Cash Flow | $9,626 | -$332 | $161,705 | $53,370 |
| Forex Effect | $763 | -$81 | $376 | $270 |
| Net Chg. in Cash | $10,767 | -$11,813 | $1,754 | $6,962 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,329 | $19,283 | $17,529 | $10,567 |
| End Cash | $17,096 | $7,470 | $19,283 | $17,529 |
| Free Cash Flow | -$64,188 | -$60,216 | -$42,027 | -$46,678 |